Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a minor maintenance update to the site’s underlying system rather than changes to study information or presentation.
    Difference
    0.0%
    Check dated 2026-08-29T20:17:33.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.5, replacing the previous v3.6.4. This update reflects a new published revision of the page without altering the study information shown.
    Difference
    0.0%
    Check dated 2026-08-08T20:13:43.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The study details page version tag was updated from Revision: v3.6.3 to Revision: v3.6.4, reflecting a small backend update to the page. This change does not alter the study information shown to users.
    Difference
    0.0%
    Check dated 2026-07-25T12:50:17.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The list of study locations was updated to 90 sites, with a new Dallas, Texas (75246) site at Texas Oncology added and several other centers removed.
    Difference
    0.5%
    Check dated 2026-07-11T06:42:59.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, marking a new iteration of the study record.
    Difference
    0.0%
    Check dated 2026-07-04T04:12:05.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page’s revision label has been updated from Revision: v3.6.0 to Revision: v3.6.2, indicating a new build of the page. This appears to be a minor maintenance update rather than a substantive change to study content.
    Difference
    0.0%
    Check dated 2026-06-27T02:04:40.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.